ADMT- warum der Anstieg weiter geht - 500 Beiträge pro Seite

[Nokian]

Nach 70 % Sprung am Donnerstag letzte Woche gibt es eine kleine Verschnaufpause um 55-60 cent, dann geht es weiter, denn chartechnisch ist der Weg frei !
Biotech vom Feinsten !

[broker2204]

gewöhnt Euch alle man an, die WKN (Wertpapierkennnummer) mit anzugeben, damit alle wissen, wovon Ihr überhaupt redet.

[Ferrando]

Tja, ein Blick auf den US-Chart belehrt uns eines besseren. Jetzt wird die Aktie von Thieme schon wieder empfohlen. Kursziel ist jetzt wohl 1 Dollar. Tja, ob da wieder ein Kurssprung möglich ist? Aber zum Glück haben wir ja den Chart, der zur Vorsicht rät! Ich wünsche jedenfalls jedem der drin ist viel Erfolg mit der Aktie.

[adiguru]

ADM Tronics Secures Third Patent On Medical Device for Treatment of Neuro-Cerebral Disorders
NORTHVALE, N.J.--(BUSINESS WIRE)--Dec. 1, 2000--The US Patent Office has issued a third patent on a non-invasive medical device for treating neuro-cerebral disorders, such as multiple sclerosis and Parkinson`s disease, developed at ADM Tronics Unlimited, Inc. (OTCBB - ADMT).

The new patent entitled, ``Corona Discharge Beam Treatment of Neuro-Cerebral Disorders`` further covers a therapeutic electronic medical device that non-invasively treats a patient`s neuro-cerebral condition with a pulsatory corona discharge of a complex electronic energy signal.

The technology covered by the three patents, called ``NCCD`` for Neuro-Cerebral Corona Discharge, was invented by Dr. Alfonso Di Mino, President and founder of ADM Tronics and Andre` Di Mino, Executive Vice President. The patents have been assigned to ADM Tronics. ``I am pleased that we have another patent for the NCCD,`` stated Dr. Di Mino. ``I hope that it will soon be able to help many people suffering from neuro-cerebral disorders.``

Initial limited clinical testing with the NCCD has been promising. However, ADM Tronics` management cautions that it believes widespread availability of this therapy is, at least, several years off. In addition to exploring clinical testing of the NCCD to assemble data for presentation to the FDA, the Company is seeking strategic relationships to assist moving the technology through the clinical and regulatory process.

ADM Tronics is a technology based developer and manufacturer of a diversified line of products categorized into three distinct market segments - therapeutic, non-invasive electronic medical devices, environmentally safe chemical products and innovative topical dermatological products.

Statements contained in this release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties (detailed in the Company`s filings with the Securities and Exchange Commission) that could cause actual results to differ materially from estimated results.


--------------------------------------------------------------------------------
Contact:

ADM Tronics Unlimited Inc., Northvale
Andre` Di Mino, 201/767-6040
Fax: [phone]
[e-mail]

[TomOdo]

Wie und wo kann ich diese Aktie ordern?

Ist dies bei Consors möglich?